Downregulated E-Cadherin Expression Indicates Worse Prognosis in Asian Patients with Colorectal Cancer: Evidence from Meta-AnalysisReportar como inadecuado




Downregulated E-Cadherin Expression Indicates Worse Prognosis in Asian Patients with Colorectal Cancer: Evidence from Meta-Analysis - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Background

Epithelial-mesenchymal transition EMT plays a crucial role in the progression and aggressiveness of colorectal carcinoma. E-cadherin is the best-characterized molecular marker of EMT, but its prognostic significance for patients with CRC remains inconclusive.

Methodology

Eligible studies were searched from the PubMed, Embase and Web of Science databases. Correlation between E-cadherin expression and clinicopathological features and prognosis was analyzed. Subgroup analysis was also performed according to study location, number of patients, quality score of studies and cut-off value.

Principal Findings

A total of 27 studies comprising 4244 cases met the inclusion criteria. Meta-analysis suggested that downregulated E-cadherin expression had an unfavorable impact on overall survival OS of CRC n = 2730 in 14 studies; HR = 2.27, 95%CI: 1.63–3.17; Z = 4.83; P = 0.000. Subgroup analysis indicated that low E-cadherin expression was significantly associated with worse OS in Asian patients n = 1054 in 9 studies; HR = 2.86, 95%CI: 2.13–3.7, Z = 7.11; P = 0.000 but not in European patients n = 1552 in 4 studies; HR = 1.14, 95%CI: 0.95–1.35, Z = 1.39; P = 0.165. In addition, reduced E-cadherin expression indicated an unfavorable OS only when the cut off value of low E-cadherin expression was >50% n = 512 in 4 studies; HR = 2.08, 95%CI 1.45–2.94, Z = 4.05; P = 0.000. Downregulated E-cadherin expression was greatly related with differentiation grade, Dukes- stages, lymphnode status and metastasis. The pooled OR was 0.3695%CI: 0.19–0.7, Z = 3.03, P = 0.002, 0.3495%CI: 0.21–0.55, Z = 6.61, P = 0.000, 0.4995%CI: 0.32–0.74, Z = 3.02, P = 0.002 and 0.4595%CI: 0.22–0.91, Z = 3.43, P = 0.001, respectively.

Conclusions

This study showed that low or absent E-cadherin expression detected by immunohistochemistry served as a valuable prognostic factor of CRC. However, downregulated E-cadherin expression seemed to be associated with worse prognosis in Asian CRC patients but not in European CRC patients. Additionally, this meta-analysis suggested that the negative threshold of E-cadherin should be >50% when we detected its expression in the immunohistochemistry stain.



Autor: Xin He , Zhigang Chen , Minyue Jia, Xiaoying Zhao

Fuente: http://plos.srce.hr/



DESCARGAR PDF




Documentos relacionados